newsfilter
← Latest News
GlobeNewswire·

Ziopharm Oncology Announces Strategic Reduction in Workforce and Extension in Cash Runway

• Over 50% reduction in personnel • Cost reductions expected to extend the cash runway into the first half of 2023 • The first patient in its TCR-T Library Phase I/II clinical trial is expected to be dosed in 1H2022 BOSTON and HOUSTON, Sep